1. Derivation of human embryonic stem cells in defined conditions
- Author
-
Christine A. Daigh, Tenneille Ludwig, Jennifer L. Frane, Mark E. Levenstein, Rachel A. Llanas, Leann J Crandall, Marian S Piekarczyk, Erika R Mitchen, Jeffrey M. Jones, W. Travis Berggren, Kevin R. Conard, and James A. Thomson
- Subjects
Cell Survival ,medicine.medical_treatment ,Cellular differentiation ,Basic fibroblast growth factor ,Biomedical Engineering ,Cell Culture Techniques ,Bioengineering ,Biology ,Applied Microbiology and Biotechnology ,Cell Line ,chemistry.chemical_compound ,medicine ,Humans ,Cell Proliferation ,Tissue Engineering ,Cell growth ,Growth factor ,Stem Cells ,Embryo ,Cell Differentiation ,Embryonic stem cell ,Cell biology ,Culture Media ,chemistry ,Cell culture ,Immunology ,Molecular Medicine ,Stem cell ,Biotechnology - Abstract
We have previously reported that high concentrations of basic fibroblast growth factor (bFGF) support feeder-independent growth of human embryonic stem (ES) cells, but those conditions included poorly defined serum and matrix components. Here we report feeder-independent human ES cell culture that includes protein components solely derived from recombinant sources or purified from human material. We describe the derivation of two new human ES cell lines in these defined culture conditions.
- Published
- 2005